Tourette Syndrome Treatment Global Market Opportunities And Strategies To 2033

Description

Tourette syndrome treatment refers to medical therapies and pharmaceutical interventions designed to manage the symptoms of Tourette Syndrome (TS), a neurological disorder characterized by repetitive, involuntary movements and vocalizations known as tics.

The tourette syndrome treatment market consists of sales, by entities (organizations, sole traders and partnerships), of tourette syndrome treatment products that are tailored to reduce the frequency, intensity and interference of tics on daily life, improving the quality of life for individuals living with TS. Medications used for TS often involve off-label prescriptions that are selected for their efficacy in controlling tic activity or addressing related conditions like attention-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD), which frequently co-occur with Tourette Syndrome.

The global tourette syndrome treatment market was valued at $1,949.93 million in 2018 which grew till $2,230.0 million in 2023 at a compound annual growth rate (CAGR) of more than 2.00%.

Growth In the Number Of Healthcare Facilities

During the historic period, growth in the number of healthcare facilities including hospitals and specialized facilities drove the tourette syndrome treatment market. The increasing number of healthcare facilities, notably hospitals and specialist cancer clinics, has increased access to modern medical therapies like tourette syndrome treatment. Patients that had better access to healthcare services in their areas, decreased the need to travel to distant medical institutions for treatment. For example, according to the 2020 AHA Annual Survey (a survey of the American Hospital Association representing comprehensive data of nearly 6,300 hospitals and more than 400 health care systems), the number of registered hospitals in the USA increased from 6,146 in 2018 to 6,210 in 2019. Also, the number of public and private hospitals in India increased from 37,725 in 2017 to 69,000 in 2019. Therefore, this growth in the number of healthcare facilities increased the demand for the tourette syndrome treatment market.

New Treatment Approvals For Rett Syndrome Patients

Companies operating in the tourette syndrome treatment market are focusing on new treatment approvals for rett syndrome patients. For instance, in October 2024, Acadia Pharmaceuticals, a US-based biotechnology company, announced that Health Canada has approved DAYBUE (trofinetide) for the treatment of Rett syndrome, marking a significant milestone as the first and only therapy authorized in Canada for this rare neurodevelopmental disorder. This approval is granted to both adult and pediatric patients aged two years and older. Rett syndrome primarily affects females and is characterized by developmental regression after normal early development, with symptoms including loss of communication skills and gait abnormalities. This approval makes DAYBUE, the first and only authorized treatment, filling a major gap for both patients and healthcare providers.

The global tourette syndrome treatment market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 41.2% of the total market in 2023.

Tourette Syndrome Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global tourette syndrome treatment market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for tourette syndrome treatment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The tourette syndrome treatment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider tourette syndrome treatment market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by treatment type, by end-use and by application.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the tourette syndrome treatment market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by treatment type, by end-use and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for tourette syndrome treatment providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Treatment Type: Antiadrenergic Agents; Antipsychotic Agents; Carbonic Anhydrase Inhibitor Anticonvulsants; Other Treatments
2) By End-Use: Hospitals; Specialty Clinics; Other End-Users
3) By Application: Children; Adult
Companies Mentioned: AbbVie Inc.; Viatris Inc.; Eli Lilly and Company; H. Lundbeck AS; Bayer AG
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; tourette syndrome treatment indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1433

1 Executive Summary

1.1 Tourette Syndrome Treatment - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Tourette Syndrome Treatment Market Definition And Segmentations
6.4 Market Segmentation By Treatment Type
- 6.4.1 Antiadrenergic Agents
- 6.4.2 Antipsychotic Agents
- 6.4.3 Carbonic Anhydrase Inhibitor Anticonvulsants
- 6.4.4 Other Treatments
6.5 Market Segmentation By End-Use
- 6.5.1 Hospitals
- 6.5.2 Specialty Clinics
- 6.5.3 Other End-Users
6.6 Market Segmentation By Application
- 6.6.1 Children
- 6.6.2 Adult

7 Major Market Trends

7.1 Innovative Drugs Aim To Provide New Hope For Tourette Syndrome Patients
7.2 New Treatment Approvals For Rett Syndrome Patients

8 Tourette Syndrome Treatment Market - Macro Economic Scenario

8.1 COVID-19 Impact On The Tourette Syndrome Treatment Market
8.2 Impact Of The War In Ukraine On The Tourette Syndrome Treatment Market
8.3 Impact Of High Inflation On The Tourette Syndrome Treatment Market

9 Global Market Size and Growth

9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 - 2023
- 9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
- 9.3.1 Market Drivers 2023 - 2028
- 9.3.2 Market Restraints 2023 - 2028

10 Global Tourette Syndrome Treatment Market Segmentation

10.1 Global Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Tourette Syndrome Treatment Market, Regional and Country Analysis

11.1 Global Tourette Syndrome Treatment Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Tourette Syndrome Treatment Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary
- 12.1.1 Market Overview
- 12.1.2 Region Information
- 12.1.3 Market Information
- 12.1.4 Background Information
- 12.1.5 Government Initiatives
- 12.1.6 Regulations
- 12.1.7 Regulatory Bodies
- 12.1.8 Major Associations
- 12.1.9 Taxes Levied
- 12.1.10 Corporate Tax Structure
- 12.1.11 Investments
- 12.1.12 Major Companies
12.2 Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Tourette Syndrome Treatment Market: Country Analysis
12.6 China Market
12.7 Summary
- 12.7.1 Market Overview
- 12.7.2 Country Information
- 12.7.3 Market Information
- 12.7.4 Background Information
- 12.7.5 Government Initiatives
- 12.7.6 Regulations
- 12.7.7 Regulatory Bodies
- 12.7.8 Major Associations
- 12.7.9 Taxes Levied
- 12.7.10 Corporate Tax Structure
- 12.7.11 Major Companies
12.8 China Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.9 China Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary
- 13.1.1 Market Overview
- 13.1.2 Region Information
- 13.1.3 Market Information
- 13.1.4 Background Information
- 13.1.5 Government Initiatives
- 13.1.6 Regulations
- 13.1.7 Regulatory Bodies
- 13.1.8 Major Associations
- 13.1.9 Taxes Levied
- 13.1.10 Corporate Tax Structure
- 13.1.11 Investments
- 13.1.12 Major Companies
13.20 Western Europe Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Tourette Syndrome Treatment Market: Country Analysis
13.6 UK Market
13.7 UK Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.8 UK Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 Germany Market
13.11 Germany Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 France Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.18 Italy Market
13.19 Italy Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Spain Market
13.23 Spain Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary
- 14.1.1 Market Overview
- 14.1.2 Region Information
- 14.1.3 Market Information
- 14.1.4 Background Information
- 14.1.5 150
- 14.1.6 150
- 14.1.7 150
- 14.1.8 150
- 14.1.4 Government Initiatives
- 14.1.5 Regulations
- 14.1.6 Regulatory Bodies
- 14.1.7 Major Associations
- 14.1.8 Taxes Levied
- 14.1.9 Corporate Tax Structure
- 14.1.10 Investments
- 14.1.11 Major companies
14.2 Eastern Europe Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Tourette Syndrome Treatment Market: Country Analysis
14.6 Russia Market
14.7 Russia Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary
- 15.1.1 Market Overview
- 15.1.2 Region Information
- 15.1.3 Market Information
- 15.1.4 Background Information
- 15.1.5 Government Initiatives
- 15.1.6 Regulations
- 15.1.7 Regulatory Bodies
- 15.1.8 Major Associations
- 15.1.9 Taxes Levied
- 15.1.10 Corporate Tax Structure
- 15.1.11 Investments
- 15.1.12 Major Companies
15.2 North America Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Tourette Syndrome Treatment Market: Country Analysis
15.6 USA Market
15.7 Summary
- 15.7.1 Market Overview
- 15.7.2 Country Information
- 15.7.3 Market Information
- 15.7.4 Background Information
- 15.7.5 Government Initiatives
- 15.7.6 Regulations
- 15.7.7 Regulatory Bodies
- 15.7.8 Major Associations
- 15.7.9 Taxes Levied
- 15.7.10 Corporate Tax Structure
- 15.7.11 Investments
- 15.7.12 Major Companies
15.8 USA Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.9 USA Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary
- 16.1.1 Market Overview
- 16.1.2 Region Information
- 16.1.3 Market Information
- 16.1.4 Background Information
- 16.1.5 Government Initiatives
- 16.1.6 Regulations
- 16.1.7 Regulatory Bodies
- 16.1.8 Major Associations
- 16.1.9 Taxes Levied
- 16.1.10 Corporate Tax Structure
- 16.1.11 Investments
- 16.1.12 Major Companies
16.2 South America Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Tourette Syndrome Treatment Market: Country Analysis
16.6 Brazil Market
16.7 Brazil Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary
- 17.1.1 Market Overview
- 17.1.2 Region Information
- 17.1.3 Market Information
- 17.1.4 Background Information
- 17.1.5 Government Initiatives
- 17.1.6 Regulations
- 17.1.7 Regulatory Bodies
- 17.1.8 Major Associations
- 17.1.9 Taxes Levied
- 17.1.10 Corporate Tax Structure
- 17.1.11 Investments
- 17.1.12 Major Companies
17.2 Middle East Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary
- 18.1.1 Market Overview
- 18.1.2 Region Information
- 18.1.3 Market Information
- 18.1.4 Background Information
- 18.1.5 Government Initiatives
- 18.1.6 Regulations
- 18.1.7 Regulatory Bodies
- 18.1.8 Major Associations
- 18.1.9 Taxes Levied
- 18.1.10 Corporate Tax Structure
- 18.1.11 Investments
- 18.1.12 Major Companies
18.2 Africa Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

19.1 Company Profiles
19.2 AbbVie Inc.
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Financial Overview
19.3 Viatris Inc
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Financial Overview
19.4 Eli Lilly and Company
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Financial Overview
19.5 H. Lundbeck AS
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
19.6 Bayer AG
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Financial Overview

20 Other Major And Innovative Companies

20.1 Neurocrine Biosciences Inc
- 20.1.1 Company Overview
- 20.1.2 Products and Services
20.2 AstraZeneca plc
- 20.2.1 Company Overview
- 20.2.2 Products and Services
20.3 Bristol-Myers Squibb Co.
- 20.3.1 Company Overview
- 20.3.2 Products and Services
20.4 F Hoffmann-La Roche AG
- 20.4.1 Company Overview
- 20.4.2 Products and Services
20.5 Amneal Pharmaceuticals Inc.
- 20.5.1 Company Overview
- 20.5.2 Products and Services
20.6 Novartis International AG
- 20.6.1 Company Overview
- 20.6.2 Products and Services
20.7 Jazz Pharmaceuticals plc
- 20.7.1 Company Overview
- 20.7.2 Products and Services
20.8 Sunovion Pharmaceuticals Inc.
- 20.8.1 Company Overview
- 20.8.2 Products and Services
20.9 Supernus Pharmaceuticals Inc.
- 20.9.1 Company Overview
- 20.9.2 Products and Services
20.10 Otsuka Pharmaceutical Co. Ltd.
- 20.10.1 Company Overview
- 20.10.2 Products and Services
20.11 Eisai Co. Ltd.
- 20.11.1 Company Overview
- 20.11.2 Products and Services
20.12 Mitsubishi Tanabe Pharma Corporation
- 20.12.1 Company Overview
- 20.12.2 Products and Services
20.13 NeuroSigma Inc.
- 20.13.1 Company Overview
- 20.13.2 Products and Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 Collegium Pharmaceutical Acquired Ironshore Therapeutics
23.2 Saladax Biomedical Inc Acquired Janssen Pharmaceutica NV

24 Opportunities And Strategies

24.1 Global Tourette Syndrome Treatment Market In 2028 - Countries Offering Most New Opportunities
24.2 Global Tourette Syndrome Treatment Market In 2028 - Segments Offering Most New Opportunities
24.3 Global Tourette Syndrome Treatment Market In 2028 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Tourette Syndrome Treatment Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer